Your browser doesn't support javascript.
loading
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.
Taiwo, Babafemi O; Chew, Kara W; Moser, Carlee; Wohl, David Alain; Daar, Eric S; Li, Jonathan Z; Greninger, Alexander L; Bausch, Christoph; Luke, Thomas; Hoover, Keila; Neytman, Gene; Giganti, Mark J; Olefsky, Maxine; Javan, Arzhang Cyrus; Fletcher, Courtney V; Eron, Joseph J; Currier, Judith S; Hughes, Michael D; Smith, Davey M.
Afiliação
  • Taiwo BO; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Chew KW; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Moser C; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Wohl DA; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Daar ES; Lundquist Institute, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.
  • Li JZ; Department of Medicine, Harvard Medical School, Cambridge, Massachusetts, USA.
  • Greninger AL; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA.
  • Bausch C; SAB Biotherapeutics, Inc, Sioux Falls, South Dakota, USA.
  • Luke T; Miami Clinical Research, Miami, Florida, USA.
  • Hoover K; Miami Clinical Research, Miami, Florida, USA.
  • Neytman G; Quantum Clinical Trials, Miami, Florida, USA.
  • Giganti MJ; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Olefsky M; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Javan AC; Division of Acquired Immune Deficiency Syndrome, National Institutes of Health, Bethesda, Maryland, USA.
  • Fletcher CV; Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Eron JJ; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Currier JS; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Hughes MD; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Smith DM; Department of Medicine, University of California San Diego, La Jolla, California, USA.
J Infect Dis ; 228(2): 133-142, 2023 07 14.
Article em En | MEDLINE | ID: mdl-36661240

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos